Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Danish Cancer Society | OTHER |
| DLHM - Danish Society for Mouth and Throat Cancer | UNKNOWN |
| Danish Network for Mouth and Throat Cancer | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The current study aims to assess the efficacy of manual treatment with craniosacral therapy of fascial tissue in throat, neck, cranial and mouth region, on radiation and/or surgery-induced salivary gland hypofunction and xerostomia in patients who have received surgery and/or radiation therapy because of cancer in the throat and mouth regions.
The hypothesis of this project is based on a recent clinical case treated by me: I practice as a physiotherapist and craniosacral therapist in a private clinic. The patient in question was treated with craniosarcal techniques (techniques that, in a broad sense, mobilizes the fascia, including meninges, dura, sleeves around the nerve-tissue etc.). He suffered from xerostomia and hyposaliva after neck surgery and radiation therapy four years prior to my treatment. During the second treatment of fascial release of the scar tissue and of the tissue around atlas, axis and occiput the patient strongly felt that his saliva started flowing. He received an additional 3 treatments, with fascial release techniques in neck, throat meninges and mouth regions, and three months after his last treatment the patient still reported much better production of saliva than before start of treatment. Furthermore, the patient reported significant gains in ease of speaking and eating. This project aim to assess if this was only an isolated event or if craniosacral therapy could be an evidence based method to increase saliva production and decrease xerostomia for patients after surgical and radiation therapy.
The aim of my project is to examine if craniosacral therapy in chest, throat, neck, cranium and mouth can decrease xerostomia in people who suffer from this after radiation therapy and/or surgery in neck or mouth because of cancer in mouth or throat. If successful, the project will be the first step in developing a clinically relevant treatment option for the growing number of patients suffering from xerostomia after radiotherapy in the throat and mouth area. This is needed, as only sub-optimal symptomatic treatments are currently available and xerostomia has been shown to reduce the quality of life. This study is inspired by a recent Danish project. In this study, stem cell therapy showed clinically significant improvements on both patient-reported measures and measured the amount of saliva produced. The authors suggest that the results may be due to a reduction of connective tissue and increased blood flow in the areas affected by radiation therapy. The authors proceed to suggest that hyperbaric oxygen treatment or other treatments attempting to increase blood flow in the radiation-affected areas could be used in combination with stem cell treatment to achieve a synergistic effect.
The hypothesis that treatment that increases the blood flow in fibrous tissue damaged after surgery or radiation has a positive effect on the tissue and its associated physiologic functions is echoed in an article about strength and shoulder mobility after breast cancer surgery. In the Danish national guidelines for breast cancer, it is also recommended that women that receive radiation therapy for their breasts because of cancer, shall receive instruction in how to treat their radiated tissue manually. The writers of the two last sources hypothesize that manual treatment of fibrous tissue damaged after surgery and radial therapy can prevent tightness in fascia and nerve tissue and preserve a proper function and mobility in shoulder and arm. The writers of the first article claims that the good results after treatment and exercises is partly attributable to the increased blood flow in the area.
A case study with 15 participants that in average 8 years previously has been through surgery or radial treatment because af cancer and who suffered from dysphagia because of fibrous tissue and neuropathy, showed that the symptoms dysphagia, airway problems and decreased mobility in the neck would be lowered by manual fascial techniques.The effect of any xerostomia was not monitored, but the study that reveals a new way to treat some of the other sequelae fibrous tissue ind mouth and neck can cause, support my hypothesis that manual treatment of fibrous tissue caused of surgery and/or radial therapy can cause increased tissue mobility, nerve conduction, and function in the fibrous tissue.
In my project I will use the treatment protocol "Avenue of expression"and a few steps from the protocol "Ten steps protocol"which addresses the areas I expect to develop fibrous tissue after radial therapy and/or surgery in neck or head. The techniques used in these protocols is light (5 grams) manual craniosacral techniques, addressing the fascia in the airway system, the neck, the throat, the meninges and nerve sleeves in the cranium, the visceral cranium, and the soft tissue in the mouth. My rationale in this project is that manual treatment of scar tissue and tissue damaged by radiation will increase mobility and blood flow and therefore possibly increase the production of saliva and decrease the sense of xerostomia.
The manual treatment is combined with home exercises that targets posture in upper body and respiration. This for maintaining the effects of the manual treatment.
Second purpose of the project is to examine if the intervention has any effect on other well-known late sequelae after treatment of cancer in mouth and neck.
Outcome is measured by a xerostomia questionaire inspired by the one used in "efficacy of the bioextra dry mouth care system in the treatment of radiotherapy induced xerostomia by Dirix P. Etal, and by selfreporting. "
My project is the very first step into supporting my hypothesis. If the results of the treatments are promising, it is my plan to continue with further research and include a placebo group and a larger sample of participants.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cranoisacral Therapy Receivers | Experimental | The participants will receive 50 minutes of treatment of craniosacral therapy once a week in 5 weeks. The treatment will follow the protocol "avenue of expression" end step 2c and 2c in "Ten step protocol". Instructions in home exercises is given. Before treatment the participants fill in the questionnaire "Xerostomia questionnaire after min 3 months" - a Danish standardized questionnaire of xerostomia used in hospitals. They will fill in this questionnaire again after ending their 5 treatment sessions, and again 6 months later as a follow up. They will also take notes in a diary of any side effects experienced during the treatment period. I will take their full medical history the first time we meet, I will take notes describing my treatment after every treatment session, including notes of the effects (positive and negative) that the participant has noticed. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Craniosacral Therapy | Other | Manual treatment, 5 grams, on the airway system, the throat, the neck, the meninges, the cranial nerve sleeves, the visceral cranium, and the soft tissue in the mouth. |
| Measure | Description | Time Frame |
|---|---|---|
| Xerostomia Questionnaire | A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does [question subject] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) the sum of points from the 15 questions gives an overall score. | Baseline (before start of this study intervention, but at least two years after finishing treatment of cancer) |
| Xerostomia Questionnaire | A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does [question subject] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) The sum of points from the 15 questions gives an overall score. | At the start of the fifth and last treament (intervention of this study). . |
| Xerostomia Questionnaire | A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does [question subject] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) The sum of points from the 15 questions gives an overall score. |
| Measure | Description | Time Frame |
|---|---|---|
| Late Sequelae at Baseline | A history is taken before the first treatment, where I asked if the participant suffered from 11 other well-known late seguela in this patient group. I asked for: dry mouth obstipation lymphedema tinnitus difficulty swallowing tense/stiff neck problems with respiration stiff jaw difficulty with speaking fatigue difficulty sleeping pain This is noted in their patient-record. Following is the number of participants who report suffering from a particular late sequelae. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cathrine T Rahbek, Cst t | Rahbek KST | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Center for Kræft og Sundhed | Copenhagen | 2200 | Denmark | |||
| - Rahbek kraniosakralterapi -FysioDanmark Skødstrup |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28431302 | Background | Hoxbroe Michaelsen S, Gronhoj C, Hoxbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017 Jun;78:91-102. doi: 10.1016/j.ejca.2017.03.006. Epub 2017 Apr 18. | |
| 29678523 | Background | Gronhoj C, Jensen DH, Vester-Glowinski P, Jensen SB, Bardow A, Oliveri RS, Fog LM, Specht L, Thomsen C, Darkner S, Jensen M, Muller V, Kiss K, Agander T, Andersen E, Fischer-Nielsen A, von Buchwald C. Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX). Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):581-592. doi: 10.1016/j.ijrobp.2018.02.034. Epub 2018 Mar 6. |
| Label | URL |
|---|---|
| National Clinical Guideline for Consequences After Surgery for Breast Cancer | View source |
Not provided
The plan is to get the results released as an research article Upledger Institute Internationals research database. The results will be accessible for everyone who is interested. I will also share it in Danish networks for interdisciplinary colleagues, and with relevant patient associations
I will keep the data at my desktop for at least 10 years
They will be in Danish and will not be on a website - i will translate them if you contact me on my mail address.
Not provided
No pre-assigment details.
Recruitment is done by sharing information of the project during network events for people who have been through treatment of cancer in mouth, head and/or neck. These events have been arranged by two patient associations -"DLHM" and "Netværket for Hals og Mundhulecancer" - two groups organized under the Danish Cancer Society.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Craniosacraltherapy Receivers | The participants will receive 50 minutes of craniosacral therapy weekly for five weeks.The treatment will follow the protocol "avenue of expression" and step 2c and 2c in "Ten step protocol" . They will get instructions in exercises targeting the upper posture and respiration to do at home between treatments. Before treatment the participants fill in the questionnaire " Xerostomia questionnaire after 3 months" - a Danish standardized questionnaire of xerostomia used in hospitals. They will fill in this questionnaire again after ending their 5 treatment sessions, and again 6 months later as follow up. They will also fill in a diary with any side effects experienced during the treatment period. I will take their full history the first time we meet, I journal my treatment after every treatment session, and journal which effects (positive and negative) the participant has noticed. Craniosacral therapy: Manual treatment on the whole airway system, the throat, the neck, the meninges, the cranium, nerve sleeves, the visceral cranium, and the soft tissue in the mouth. Exercises - targeting the upper posture and respiration. |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Apr 24, 2020 | Apr 28, 2025 |
Not provided
Pilot project - single group intervention with before-after comparisons.
Not provided
Not provided
The person who does the statistic analysis will not have participated in the treatments and will not have met the participants.
Not provided
|
| Exercices Targeting Upper Posture and Respiration | Other | Exercises targeting upper posture and breathing exercises. The exercises is given when the therapist has reached some anatomical milestones in the treatment protocol. For example, an exercise with diaphragmatic breathing is given after manual treatment of diaphragma. |
|
| 6 months post after finishing the craniosacral treatment (the intervention in this study) |
| baseline |
| Number of Partcipants Who Experienced a Decrease in Symptoms With Their Late Sequela the 5. Time of Treatment | A history is taken before the first treatment, where I asked if the participant suffered from 11 other well-known late sequela. At the 5. and last treatment I asked then if they observed any changes in their late seguela (better or worse) - They did not report any worsening of their late sequela, but a number of participants reported some positive changes.The selfreported change in symptoms is noted in their patient record. The following is the number of participants, who observed a positive change( a decrease in symptoms) in their late sequeale. | The 5. and last time of treatment(intervention of this study) |
| Number of Partcipants Who Experienced a Decrease in Symptoms With Their Late Sequela at 6 Month Follow-up | A history was taken before the first treatment, where I asked if the participant suffered from 11 other well-known late sequelae in this patient group. The 5. time and 6 months after end of treatment, I asked if they observed any differences (better or worse) with their late sequelae an noted it down in their patientrecord.. They have not reported any worsening of late sequela - the following is the number of participants who reported a possitive change (a decrease in symptomps) in their late sequela at 6 month following. | 6 month after finishng the craniosacral treatment( intervention of this study) |
| Skødstrup |
| Ã…rhus |
| 8530 |
| Denmark |
| 14731584 | Background | Lauridsen MC, Torsleff KR, Husted H, Erichsen C. Physiotherapy treatment of late symptoms following surgical treatment of breast cancer. Breast. 2000 Feb;9(1):45-51. doi: 10.1054/brst.1999.0087. |
| 17235501 | Background | Dirix P, Nuyts S, Vander Poorten V, Delaere P, Van den Bogaert W. Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer. 2007 Dec;15(12):1429-36. doi: 10.1007/s00520-006-0210-y. Epub 2007 Jan 18. |
| The Role of Myofascial and Manual Therapy in Dysphagia Treatment | View source |
| Article based on this reseach: Can Late Effects After Treatment for Throat and Oral Cavity Cancer Be Reduced with CranioSacral Therapy? Experiences and Considerations in Treating Late Effects with CranioSacral Therapy - A Guide for Professionals | View source |
| COMPLETED | Eleven participants completed the treatment, but one was excluded. |
|
| NOT COMPLETED |
|
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Craniosacraltherapy Receivers | Receiving 5 treatments of craniosacraltherapy , following the protocol " avenue of expression". They are also being instructed in specific exersises |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Participants were asked about their age at baseline | Mean | Full Range | years |
| ||||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||||
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
| |||||||||||||||||
| Region of Enrollment | Number | participants |
| ||||||||||||||||||
| results of questionaire | Baseline measures in the questionnaire included an xerostomia VAS scale ranging from 0(none) - 10 (worst) The remaining 14 questions were phrased "how much does [question subject] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) the sum of points from the 15 questions gives an overall score. | Mean | Full Range | units on a scale |
| ||||||||||||||||
| time after cancertreatment | Mean | Full Range | years |
| |||||||||||||||||
| Type of cancertreatment | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Xerostomia Questionnaire | A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does [question subject] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) the sum of points from the 15 questions gives an overall score. | 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale | Posted | Mean | Full Range | score on a scale | Baseline (before start of this study intervention, but at least two years after finishing treatment of cancer) |
|
|
| ||||||||||||||||||||||||||||||||
| Primary | Xerostomia Questionnaire | A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does [question subject] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) The sum of points from the 15 questions gives an overall score. | 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale | Posted | Mean | Full Range | Score on a scale | At the start of the fifth and last treament (intervention of this study). . |
| ||||||||||||||||||||||||||||||||||
| Primary | Xerostomia Questionnaire | A Danish questionnaire for following up on patients who have finished their cancer treatment in head and neck on a Danish hospital. It is used at least 3 months after treatment. The participants in this study has finished their treatment for cancer at least two years from enroling this study. VAS xerostomia scale0-10 (10 is worst) The remaining 14 questions were phrased "how much does [question subject] bother you:" (translated from Danish) not at all (1) - a little (2) - some (3) a lot (4) very much( 5) The final question(number 15) were: "How would you feel, if you had to live the rest of your life, with the symptoms you have now?:" enjoyable(1), very satisfied (2) neither satisfied ore unsatisfied(3), very unsatisfied(4), terrible(5) The sum of points from the 15 questions gives an overall score. | 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale | Posted | Mean | Full Range | score on a scale | 6 months post after finishing the craniosacral treatment (the intervention in this study) |
| ||||||||||||||||||||||||||||||||||
| Secondary | Late Sequelae at Baseline | A history is taken before the first treatment, where I asked if the participant suffered from 11 other well-known late seguela in this patient group. I asked for: dry mouth obstipation lymphedema tinnitus difficulty swallowing tense/stiff neck problems with respiration stiff jaw difficulty with speaking fatigue difficulty sleeping pain This is noted in their patient-record. Following is the number of participants who report suffering from a particular late sequelae. | 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale | Posted | Number | participants | baseline |
| |||||||||||||||||||||||||||||||||||
| Secondary | Number of Partcipants Who Experienced a Decrease in Symptoms With Their Late Sequela the 5. Time of Treatment | A history is taken before the first treatment, where I asked if the participant suffered from 11 other well-known late sequela. At the 5. and last treatment I asked then if they observed any changes in their late seguela (better or worse) - They did not report any worsening of their late sequela, but a number of participants reported some positive changes.The selfreported change in symptoms is noted in their patient record. The following is the number of participants, who observed a positive change( a decrease in symptoms) in their late sequeale. | 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale | Posted | Number | participants | The 5. and last time of treatment(intervention of this study) |
| |||||||||||||||||||||||||||||||||||
| Secondary | Number of Partcipants Who Experienced a Decrease in Symptoms With Their Late Sequela at 6 Month Follow-up | A history was taken before the first treatment, where I asked if the participant suffered from 11 other well-known late sequelae in this patient group. The 5. time and 6 months after end of treatment, I asked if they observed any differences (better or worse) with their late sequelae an noted it down in their patientrecord.. They have not reported any worsening of late sequela - the following is the number of participants who reported a possitive change (a decrease in symptomps) in their late sequela at 6 month following. | 11 participants entered the project. 1 participant was not analysed, because of to low score at the xerostomia vas-scale i baseline. The inclusioncriteria for entering the analysis phase of the project was a score at at least 4 n the xerostomia vas-scale | Posted | Count of Participants | Participants | 6 month after finishng the craniosacral treatment( intervention of this study) |
|
5 weeks. There has not been asked for adverse events after end of treatment and there has not been reported any (through spontaneous reports while going over the trial with all participants) at 6 months follow up.
Diary, asking about adverse events at every treatment. There has not been asked for adverse events after end of treatment and there has not been reported any (through spontaneous reports while going over the trial with all participants) at 6 months follow up.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Cranoisacraltherapy Receivers | receivers of cranoisacral therapy and home exercises | 0 | 10 | 0 | 10 | 7 | 10 |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| dizziness | General disorders | Non-systematic Assessment | dizziness |
| |
| irritability | General disorders | irritability | Non-systematic Assessment | irritability |
|
| headache | General disorders | Non-systematic Assessment |
| ||
| sore neck /upper back | General disorders | Non-systematic Assessment |
| ||
| cramp in the neck | General disorders | Non-systematic Assessment |
| ||
| sore floor of mouth | General disorders | Non-systematic Assessment |
| ||
| more dislocation of the jaw than usual | General disorders | Non-systematic Assessment |
| ||
| tight jaws | General disorders | Non-systematic Assessment |
| ||
| difficulty controlling the tongue | General disorders | Non-systematic Assessment |
| ||
| reactions on the ears | General disorders | Non-systematic Assessment |
| ||
| runny nose | General disorders | Non-systematic Assessment |
| ||
| more coughing and secretion than usual | General disorders | Non-systematic Assessment |
| ||
| a feeling of pressure in the chest (not angina pectoris) | General disorders | Non-systematic Assessment |
| ||
| more thirst | General disorders | Non-systematic Assessment |
| ||
| more hungry | Gastrointestinal disorders | Non-systematic Assessment |
| ||
| stomach ache/frequent visits to the toilet | General disorders | Non-systematic Assessment |
| ||
| need to pee more | General disorders | Non-systematic Assessment |
| ||
| feeling bloated | General disorders | Non-systematic Assessment |
| ||
| feeling tired | General disorders | Non-systematic Assessment |
| ||
| cramp in the feet | General disorders | Non-systematic Assessment |
| ||
| restlessness in the body | General disorders | Non-systematic Assessment |
|
1 participant received intervention, but was excluded before analysis because it was discovered afterwards that this participant was never eligible for inclusion (because of low score (3) in the xerostomia vas-scale at baseline - inclusion criterium was >= 4)
While scoring the xerostomia questionnaire 6 answers have inconclusive scores (either two values, or no values at all). These cases were not included when calculating the mean.
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Cathrine Rahbek | Rahbek FYS | 0045 30645390 | cathrinerahbek@outlook.dk |
| Prot_000.pdf |
| ICF | No | No | Yes | Informed Consent Form: Informed consent for participation | Dec 1, 2020 | Apr 28, 2025 | ICF_001.pdf |
| ICF | No | No | Yes | Informed Consent Form: Informed consent for publication | Jan 1, 2023 | Apr 28, 2025 | ICF_002.pdf |
| ID | Term |
|---|---|
| D014987 | Xerostomia |
| D053120 | Respiratory Aspiration |
| ID | Term |
|---|---|
| D012466 | Salivary Gland Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D012119 | Respiration |
| ID | Term |
|---|---|
| D012143 | Respiratory Physiological Phenomena |
| D002943 | Circulatory and Respiratory Physiological Phenomena |
Not provided
Not provided
| Remaining 15 questions overall sum (15 worst-75 best) |
|
|
|
|
| radiation therapy |
|
|
|
|
|
|
|
|
|
|
|
|